Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
XORTX Therapeutics Inc
V.XRTX
Alternate Symbol(s):
XRTX
Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance...
its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:XRTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(77)
•••
Investorpigs
X
View Profile
View Bullboard History
Comment by
Investorpigs
on Apr 03, 2023 2:38pm
RE:RE:Keep an eye on XRTX this week ;)
That's expected with these type of companies. So trading at 40% under cash on hand plus giving 0 value to the 19M invested last year. Low float, will fly shortly. Just watch.
(2144)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Apr 02, 2023 3:47pm
RE:Keep an eye on XRTX this week ;)
Burned through $14 million of cash last year. So only 1 year of cash left.
(77)
•••
Investorpigs
X
View Profile
View Bullboard History
Post by
Investorpigs
on Apr 01, 2023 9:24pm
Keep an eye on XRTX this week ;)
15M in $$$ and 11.5M mcap....with all this company has going on. Watch out. Easy double from here. Loading the boat Monday.
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Jan 20, 2023 10:01am
RE:RE:I told you loose money with this stock
Nothing new and I just noticed the shares out is up , nothing new to me
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 19, 2023 10:02am
XRTX..... thru last support ; )
Volume decreasing This thing could never hold a gain....leopard changing spots?
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 19, 2023 9:52am
XRTX .... In PB mode ....
has to hold and rally $1.06 u.s Or it's over
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 19, 2023 8:59am
XRTX..... Early a.m runner in the U.S on news release
Lets see how this unfolds here in Canada....old adage is : Buy on mystery ...sell on history You be the judge ; ) U.S = $ 1.07 Cad = $1.45 at 5:58 pre-market open Cheers !
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 28, 2022 7:00am
New Press Release - XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial CALGARY, Alberta, Nov. 28, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on...
read article.
(103)
•••
Peggy123
X
View Profile
View Bullboard History
Post by
Peggy123
on Nov 25, 2022 8:06pm
news out
not good
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Nov 04, 2022 10:25am
RE:I told you loose money with this stock
Did you notice they just burn cash and did pp for more cash and dilution of shareholders value
(56)
•••
NLMoose
X
View Profile
View Bullboard History
Comment by
NLMoose
on Nov 02, 2022 10:26am
RE:XORTX THERAPEUTICS: WHY THIS COMPANY IS WORTH INVESTING IN
Not worth investing when they are on a verge of going below $1.00 a share, and face possible delistment from the NASDAQ.
(56)
•••
NLMoose
X
View Profile
View Bullboard History
Post by
NLMoose
on Nov 02, 2022 10:25am
Soon XORTX Will Join "I Am Cannabis" With Delistment
With XORTX shares now approaching the critical mass of $1.00 a share, won't be long until it joins another Canadian NASDAQ failure, "I Am Cannabis", in facing delistment.
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Oct 04, 2022 9:32am
I told you loose money with this stock
It's been like that from the start
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Sep 13, 2022 8:37am
XORTX THERAPEUTICS: WHY THIS COMPANY IS WORTH INVESTING IN
$XRTV Excited to share latest coverage on XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative
...more
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 25, 2022 11:18am
Going below $2 , do not get too exited
This stock has history and not good one
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income